Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system

M Tawfik El-Mansi1, A R W Williams

  • 1Department of Pathology, Royal Infirmary of Edinburgh and University of Edinburgh, Edinburgh, Scotland, UK. magdy.elmansi@smuht.nwest.nhs.uk

Summary

Tissue microarrays (TMAs) enable large studies using archival tissues. TMAs accurately represent cervical adenocarcinoma morphology and immunohistochemical staining for diagnostic markers.

Related Concept Videos